MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

494909

Report Date :

01.03.2018

 

 

IDENTIFICATION DETAILS

 

Name :

IND SWIFT LIMITED

 

 

Registered Office :

781, Industrial Area, Phase II, Chandigarh – 160002

Tel. No.:

91-172-2638781-786/ 2638782/ 2638786

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

06.06.1986

 

 

Com. Reg. No.:

53-006897

 

 

Capital Investment / Paid-up Capital :

INR 250.329 Million

 

 

CIN No.:

[Company Identification No.]

L24230CH1986PLC006897

 

 

IEC No.:

[Import-Export Code No.]

2288001305

 

 

PAN No.:

[Permanent Account No.]

AAACI6100L

 

 

GSTN :

[Goods & Service Tax Registration No.]

04AAACI6100L1ZY

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of formulations (Registered Activity)

 

 

No. of Employees :

1252 (Approximately)

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

C

 

Credit Rating

Explanation

Rating Comments

C

Medium High Risk

Business dealings permissible preferably on secured basis

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 1986. It is engaged in manufacturing of formulations.

 

For the financial year 2017, the company has reported dip in its revenue by 13.17% as compared to the previous year along with operational loss.

 

The moderate financial risk profile of the company is marked by eroded networth base due to huge accumulated losses along with average debt balance sheet profile.

 

Further, subject has been found under RBI defaulters list, the name of credit grantor is Central Bank of India and the amount charged is INR 95.602 million dated 31.12.2017.

 

Payments seems to be slow.

 

In view of aforesaid, dealings are recommended on safe and secured terms. 

 

NOTE: Due to subject’s continuous operational loss resulting in erosion of net worth and also its availability in the list of RBI Defaulters, rating has been downgraded. Hence we do not recommend any credit limit to the subject.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name has been found enlisted as a defaulter in the publicly available RBI Defaulters’ list and the details of the same are as under :

 

Suit-filed accounts of INR 10.000 Million and above
Search details 
Borrower Containing - IND SWIFT LIMITED

 

Sr No.

Director reported by credit grantors

DIN Number

Central Bank of India

 

1

DR. GOPAL MUNJAL AAVPM2103M

00005196

2

Navrattan Munjal AAVPM2074M

00015096

3

Sanjeev Rai Mehta AAVPM2077J

00005668

 

List of credit grantors to which INR Swift Limited is a defaulters

 

Name of credit grantors

Branch

Amount

(INR in million)

Central Bank of India

Sector 17-B, Chandigarh – 160002, India

INR 95.602 Million

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 01.03.2018

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DECLINED

 

Management non-cooperative (Tel No.:91-22-42288300)

Tel No.: 91-1762-522288 (Continuously ringing)

 

LOCATIONS

 

Registered Office / Corporate Office :

781, Industrial Area, Phase II, Chandigarh – 160002, India

Tel. No.:

91-172-2638781-786/ 2638782/ 2638786

Fax No.:

91-172-2652242 / 2655406

E-Mail :

cs.indswift@gmail.com

indswiftho@indswift.com

info@indswift.com

corporate@indswift.com

Website :

http://www.indswiftltd.com

 

 

Marketing Office :

102-103, 107-109, Basement L1, The Summit-Business Bay off Western Express Highway, Vile Parle (East), Mumbai – 400057, Maharashtra, India

Tel No.:

91-22-42288300/ 42288399

Fax No.:

91-22-26184120

 

 

Factory 1 :

123, Industrial Area 1, Panchkula 134 109, Haryana, India

 

 

Factory 2 :

Plot. No. 23, Sector 2, (Unit I), Parwanoo, Himachal Pradesh, India

 

 

Factory 3 :

Plot No. 17 B, Sector 2, (Unit II) Parwanoo, Himachal Pradesh, India

 

 

Factory 4 :

Village Malku Majra, (Unit III and IV) Baddi, Himachal Pradesh, India

 

 

Factory 5 :

Global Business, Unit Off NH-21, Village Jawaharpur, Tehsil Dera Bassi - Patiala - 140507 , Punjab, India

 

 

Factory 6:

Industrial Growth Centre, Sambha, Jammu, Jammu and Kashmir, India 

 

 

R & D Office :

Plot No. R-489, TTC Industrial Area, MIDC, Rabale, Navi Mumbai – 400701, Thane, Maharashtra, India

 

 

DIRECTORS

 

As on 31.03.2017

 

Name :

Dr. Gopal Munjal

Designation :

Managing Director

Address :

House No. 1085, Sector 7, Panchkula, Haryana, India

Date of Birth/Age :

01.08.1958

Date of Appointment :

11.12.1986

DIN No.:

00005196

 

 

Name :

Mr. Sanjeev Rai Mehta

Designation :

Whole Time Director

Address :

House No. 333, Sector 6, Panchkula, Haryana, India

Date of Birth/Age :

01.08.1956

Date of Appointment :

30.11.2006

DIN No.:

00005668

 

 

Name :

Dr. Vikrant Rai Mehta

Designation :

Wole Time Director

Address :

House No. 1044, Sector 4, Panchkula, Haryana, India

Date of Birth/Age :

22.10.1958

Date of Appointment :

30.09.1993

DIN No.:

00010756

 

 

Name :

Mr. Navrattan Munjal

Designation :

Director

Address :

House No. 382, Sector 6, Panchkula, Haryana, India

Date of Birth/Age :

09.02.1952

Date of Appointment :

11.12.2006

DIN No.:

00015096

 

 

Name :

Mr. Himanshu Jain

Designation :

Director

Address :

House No. 1133, Sector 21-B, Chandigarh, India

Date of Birth/Age :

17.08.1982

Date of Appointment :

31.07.2003

DIN No.:

00014533

 

 

Name :

Mr. Rishav Mehta

Designation :

Additional Director

Address :

House No. 322, Sector 6, Panchkula, Haryana, India

Date of Birth/Age :

06.01.1991

Date of Appointment :

23.03.2010

DIN No.:

03028663

 

 

Name :

Mr. Jatender Kumar Kakkar

Designation :

Director

Address :

House No. 880, Sector-7, Panchkula -134109, Haryana, India

Date of Appointment :

13.05.2017

DIN No.:

00015493

 

 

Name :

Mr. Prakash Sharma

Designation :

Director

Address :

700, M.P. Block, Asiad Village Complex, New Delhi -110049, India 

Date of Birth/Age :

21.11.1955

Date of Appointment :

07.11.2012

DIN No.:

00475413

 

 

Name :

Mr. Jagvir Singh Ahluwalia

Designation :

Additional Director

Address :

Flat No. - 811, Block A8, Palm Court Vip Road, Zirakpur, Baltana, Mohali -140603,  Punjab, India

Date of Appointment :

29.08.2017

DIN No.:

06930649

 

 

Name :

Mr. Vinay Arora

Designation :

Director

Address :

A-97, Sector 27, Noida, 201301, Uttar Pradesh, India

Date of Appointment :

07.03.2014

DIN No.:

06830624

 

 

Name :

Mr. Brij Mohan Padha

Designation :

Nominee Director

Address :

House No. 51, Sector 2, Chandigarh, 160002, India

Date of Appointment :

29.12.2014

DIN No.:

06999443

 

 

Name :

Mr., Subhash Chander Galhotra

Designation :

Director

Address :

Flat N O. 1166, Progressive Co Op. H/B Society Sector 50-B Chandigarh 160047 , India

Date of Appointment :

31.12.2016

DIN No.:

07205416

 

 

Name :

Mr. Anoop Michra

Designation :

Director

Address :

House No. 1409, Sector 34 C, Chandigarh- 160022, India  

Date of Appointment :

06.05.2017

DIN No.:

07813108

 

 

KEY EXECUTIVES

 

Name :

Mr. Arun Sheth

Designation :

Chief Financial Officer

Address :

H.No.364, Sector 48a, Chandigarh - 160047, India

Date of Appointment :

13.02.2015

PAN No.:

ABXPS5256L

 

 

Name :

Simrat Kaur

Designation :

Company Secretary

Address :

Flat No. 2311, Telehos Society (BSNL), Sector 50 C, Chandigarh- 160047, India

Date of Appointment :

30.06.2016

PAN No.:

BUXPK0113Q

 

 

MAJOR SHAREHOLDERS

 

As on 31.12.2017

 

Category of shareholder

Total nos. shares held

Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a %

(A) Promoter & Promoter Group

30090404

55.55

(B) Public

24074249

44.45

Grand Total

54164653

100.00

 

 

Statement showing shareholding pattern of the Promoter and Promoter Group

 

Category of shareholder

Total nos. shares held

Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a %

A1) Indian

 

Individuals/Hindu undivided Family

13056971

24.11

N.R. MUNJAL

611700

1.13

NIDHI MUNJAL

502970

0.93

RAVI MEHTA

634470

1.17

S.R. MEHTA

2035871

3.76

NEETA MUNJAL

578600

1.07

V.R. MEHTA

1921361

3.55

MEENAKSHI MEHTA

398310

0.74

NEERA MEHTA

1547050

2.86

RISHAV MEHTA

111700

0.21

GOPAL MUNJAL

1957199

3.61

SUNITA JAIN

1812400

3.35

HIMANSHU JAIN

495300

0.91

ANNIE MEHTA

158630

0.29

SAHIL MUNJAL

116010

0.21

BHANAVI MEHTA

30300

0.06

SAURABH MUNJAL

51700

0.10

ISHAV MEHTA

44200

0.08

DEEPTI MUNJAL

34200

0.06

DIVYA MUNJAL

15000

0.03

Any Other (specify)

17033433

31.45

ESSIX BIOSCIENCES LIMITED

17033433

31.45

Sub Total A1

30090404

55.55

A2) Foreign

0.00

A=A1+A2

30090404

55.55

 

Statement showing shareholding pattern of the Public shareholder

 

Category & Name of the Shareholders

Total no. shares held

Shareholding % calculated as per SCRR, 1957 As a %

B1) Institutions

Mutual Funds/

4500

0.01

Foreign Portfolio Investors

700209

1.29

ALBULA INVESTMENT FUND LTD

700209

1.29

Financial Institutions/ Banks

1924

0.00

Insurance Companies

996900

1.84

UNITED INDIA INSURANCE COMPANY LIMITED

996900

1.84

Sub Total B1

1703533

3.15

B2) Central Government/ State Government(s)/ President of India

0.00

Central Government/ State Government(s)/ President of India

204074

0.38

Sub Total B2

204074

0.38

B3) Non-Institutions

0.00

Individual share capital upto INR 0.200 million

12421945

22.93

Individual share capital in excess of INR 0.200 million

1895413

3.50

SHARWAN SINGH GULERIA

762000

1.41

NBFCs registered with RBI

2504

0.00

Any Other (specify)

7846780

14.49

Clearing Members

195293

0.36

EXCEL MOTORS PRIVATE LIMITED

586000

1.08

GRAVITY SYSTEMS PRIVATE LIMITED

750000

1.38

JUSTIN PHARMACEUTICALS PRIVATE LIMITED

860000

1.59

PANCHKULA FINVEST PRIVATE LIMITED

1400000

2.58

DEEPA RAM KHERIA

575000

1.06

HUF

937819

1.73

Sub Total B3

22166642

40.92

B=B1+B2+B3

24074249

44.45

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of formulations (Registered Activity)

 

 

Products / Services :

Item Code No.

Products/Services Description

21002

formulations

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged 

 

 

Imports :

Not Divulged 

 

 

Terms :

Not Divulged 

 

PRODUCTION STATUS – (NOT AVAILABLE)

 

GENERAL INFORMATION

 

Suppliers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

Customers :

 

Reference :

Not Divulged

Name of the Person :

--

Contact No.:

--

Since How Long Known :

--

Maximum Limit Dealt :

--

Experience :

--

Remark:

--

 

 

No. of Employees :

1252 (Approximately)

 

 

Bankers :

  • Punjab National Bank, Sector 28, Chandigarh, India
  • State Bank of India, SCO 103-106, Sector-17, Chandigarh, India
  • Canara Bank, SCO 311-314, Sector 35-B, Chandigarh, India
  • IDBI Bank, Sector-17, Chandigarh, India

 

 

Facilities :

Secured Loan

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

From Banks/Asset Reconstruction Companies (ARC)

From Financial Institutions/ Asset

6018.725

6040.163

Reconstruction Companies (ARC)

427.012

430.236

 

 

 

Short-term borrowings

 

 

Borrowings for working capital are secured by a Pari-Passu, first charge by way of Hypothication of the company's current assets, namely, Stocks of Raw Materials, SemiFinished, Finished Goods, Stores and Spares not relating to Plant and Machinery (Consumbale Stores and Spares), Bills Receivable and Book Debts and all other movables of the Company both present and future excluding such movables as may be permitted by the said Banks/ Asset Reconstruction Companies (ARC) from time to time. The said facility is further secured by way of pari passu second charge on the company's immovable and movable properties (other than current assets) and personal guarantees of Directors and by way of pledge of shares of promoters.

3595.491

3499.947

Total

10041.228

9970.346

NOTES:

 

Long-term Borrowings

Term Loan from Banks and Financial Institutions are secured by way of first pari-passu charge over entire fixed assets of the company, second pari-passu charge over the entire current assets of the company, personal guarantee of Directors and by way of pledge of shares of promoters. Restructured Bill Discounting/Factoring facilities are secured by way of subservient charge over entire current assets of the company.

 

Since the Company is unable to repay the instalments and Banks have exited from the CDR mechanism, the instalments due and falling due in next twelve months have not been segregated as current liability. The entire loan amount has been shown as long term liability except loan accounts which are being repaid as per repayment schedule.

 

Auditors :

 

Name :

J. K. Jain and Associates

Chartered Accountants

Address :

S.C.O. 1132-33, Sector 22-B, Chandigarh -160 022, India

Tel No.:

91-172-2575761, 2575762

Mobile No.:

91-9316112404

Email:

jainassociates1968@gmail.com  

 

 

Legal Advisors:

 

Name :

P. K. Goklaney and Company Advocates

Address :

38, Sector 16-A, Chandigarh, India

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates:

  • Ind-Swift Laboratries Limited

 

 

Others (entities in which KMP or their relative is director, or KMP or their relative exercises control):

  • Essix Biosciences Limited
  • Halcyon Life Sciences Private Limited
  • Fortune India Construction Limited
  • Mansa Print and Publishers Limited
  • Swift Fundamental Research and Education Society
  • 3m Advertisers and Publishers Limited
  • Punjab Renewable Energy Private Limited
  • B. M. Cosmed Private Limited
  • Dashmesh Medicare Private Limited
  • Consummate Pharmaceuticals Private Limited
  • Integral Buildcon Private Limited
  • Akj Portfolios Private Limited
  • Nrm Portfolios Private Limited
  • Srm Portfolios Private Limited
  • Gm Portfolios Private Limited
  • Vrm Portfolios Private Limited
  • Vkm Portfolios Private Limited

 

 

CAPITAL STRUCTURE

 

As on 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

75000000

Equity Shares

INR 2/- each

INR 150.000 Million

2500000

Cumulative Preference Share

INR 100/- each

INR 250.000 Million

 

Total

 

INR 400.000 Million

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

54164653

Equity Shares

INR 2/- each

INR 108.329 Million

1420000

Cumulative Redeemable Preference Share

INR 100/- each

INR 142.000 Million

 

Total

 

INR 250.329 Million

 

 

b) Reconciliation of Equity and Preference Shares as on 31.03.17

 

 

31.03.2017

 

No. of Shares held

 

Equity

Preference

Opening Balance

50346941

1420000

Add: No of Shares Issued

3817712

Nil

Closing Balance

54164653

1420000

 

 

c) No. of shareholders holding 5% or more of share capital

 

Name of Shareholders

31.03.2017

 

No. of Shares held

% of Holding

Essix Biosciences Limited

9215721

17.01

 

 

 

 

d) The Preference Shares shall rank for dividends in priority to equity Shares for time being. These shares shall be entitled to rank in priority to equity shares as regards repayment of Capital and arrears of dividend declared, but shall not be entitled to any further participation in profit or assets of the Company.


 

FINANCIAL DATA

[all figures are INR Million]

 

ABRIDGED BALANCE SHEET (STANDALONE)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

250.329

242.694

242.694

(b) Reserves & Surplus

(6343.618)

(2704.306)

(704.502)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

66.810

66.810

Total Shareholders’ Funds (1) + (2)

(6093.289)

(2394.802)

(394.998)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

6647.699

6716.524

5414.093

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

48.086

56.386

62.264

(d) long-term provisions

26.375

20.402

13.999

Total Non-current Liabilities (3)

6722.160

6793.312

5490.356

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

3835.220

3712.534

3690.188

(b) Trade payables

1617.599

1753.815

1502.621

(c) Other current liabilities

621.071

742.963

1990.117

(d) Short-term provisions

0.000

0.000

0.000

Total Current Liabilities (4)

6073.890

6209.312

7182.926

 

 

 

 

TOTAL

6702.761

10607.822

12278.284

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

3146.886

3442.934

3714.870

(ii) Intangible Assets

276.237

298.507

321.688

(iii) Capital work-in-progress

22.175

22.175

22.175

(iv) Intangible assets under development

0.000

14.499

16.749

(b) Non-current Investments

451.233

451.233

451.233

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

127.871

163.122

162.626

(e) Other Non-current assets

0.000

98.900

209.554

Total Non-Current Assets

4024.402

4491.370

4898.895

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

390.598

909.405

1133.672

(c) Trade receivables

1084.810

3803.303

4854.814

(d) Cash and cash equivalents

91.051

173.896

169.830

(e) Short-term loans and advances

820.622

869.109

857.641

(f) Other current assets

291.278

360.739

363.432

Total Current Assets

2678.359

6116.452

7379.389

 

 

 

 

TOTAL

6702.761

10607.822

12278.284

 

 

PROFIT & LOSS ACCOUNT (STANDALONE)

 

 

PARTICULARS

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

Income

2672.027

3077.483

4171.665

 

Other Income

109.293

125.050

18.667

 

TOTAL

2781.320

3202.533

4190.332

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

1672.082

2190.411

2541.261

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(39.302)

14.369

993.034

 

Employees benefits expense

423.300

403.698

428.714

 

Other expenses

3833.906

2038.515

908.000

 

TOTAL

5889.986

4646.993

4871.009

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

(3108.666)

(1444.460)

(680.677)

 

 

 

 

 

Less

FINANCIAL EXPENSES

163.159

189.679

399.257

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

(3271.825)

(1634.139)

(1079.934)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

357.322

363.515

393.633

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

(3629.147)

(1997.654)

(1473.567)

 

 

 

 

 

Less

TAX

8.935

1.746

(22.291)

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

(3638.082)

(1999.400)

(1451.276)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

(4414.731)

(2415.331)

(964.055)

 

 

 

 

 

 

Balance Carried to the B/S

(8052.813)

(4414.731)

(2415.331)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

F.O.B. Value of Exports

1188.165

986.800

509.278

 

Technology Transfer Fees

18.893

22.611

12.725

 

TOTAL EARNINGS

1207.058

1009.411

522.003

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

93.505

75.066

41.377

 

Packing Material /Consumables

0.579

1.239

0.541

 

Finished Goods

0.000

9.321

0.000

 

Equipment’s

0.000

6.894

0.000

 

TOTAL IMPORTS

94.084

92.520

41.918

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

(67.17)

(39.71)

(28.83)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

 

 

 

Current Maturities of Long Term Debts

0.000

38.100

1290.328

Current Maturities of Vehicle Loan

0.000

0.295

1.483

Total

0.000

38.395

1291.811

Cash generated from operations

NA

NA

NA

Net cash flows from (used in) operations

NA

NA

NA

Net cash flows from (used in) operating activity

67.198

(1057.911)

855.748

 


 

QUARTERLY RESULTS

 

Particulars

 

30.06.2017

 (Unaudited)

30.09.2017

(Unaudited)

31.12.2017

 (Unaudited)

 

1st  Quarter

2nd Quarter

3rd Quarter

Net Sales

526.080

713.140

767.970

Total Expenditure

565.780

754.120

799.660

PBIDT (Excl OI)

(39.700)

(40.980)

(31.690)

Other Income

10.420

2.080

2.060

Operating Profit

(29.280)

(38.900

(29.630)

Interest

30.360

17.420

24.090

Exceptional Items

NA

NA

NA

PBDT

(59.640)

(56.320)

(53.720)

Depreciation

85.960

86.130

86.230

Profit Before Tax

(145.600)

(142.450)

(139.950)

Tax

NA

NA

NA

Provisions and contingencies

NA

NA

NA

Profit After Tax

(145.600)

(142.450)

(139.950)

Extraordinary Items

NA

NA

NA

Prior Period Expenses

NA

NA

NA

Other Adjustments

NA

NA

NA

Net Profit

(145.600)

(142.450)

(139.950)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

148.19

451.08

424.77

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

2.46

0.81

0.86

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

353.11

292.25

215.82

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

(7.96)

(1.59)

(0.60)

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

(0.90)

(0.38)

(0.17)

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

1.90

1.22

1.13

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

(1.72)

(4.37)

(26.32)

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

(1.00)

(2.59)

(18.18)

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

(0.57)

(1.58)

(10.32)

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

(19.05)

(7.62)

(1.70)

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

(136.15)

(64.97)

(34.79)

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

(54.28)

(18.85)

(11.82)

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

59.71

83.49

367.41

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

0.44

0.99

1.03

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.38

0.84

0.87

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

(0.91)

(0.23)

(0.03)

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

41.88

43.13

42.84

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

0.44

0.99

1.03

 

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

STOCK PRICES

 

Face Value

INR 2/-

Market Value

INR 8.70/-

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

242.694

242.694

250.329

Reserves & Surplus

(704.502)

(2704.306)

(6343.618)

Money received against share warrants

0.000

0.000

0.000

 Share Application money pending allotment

66.810

66.810

0.000

Net worth

(394.998)

(2394.802)

(6093.289)

 

 

 

 

long-term borrowings

5414.093

6716.524

6647.699

Short term borrowings

3690.188

3712.534

3835.220

Current maturities of long-term debts

1291.811

38.395

0.000

Total borrowings

10396.092

10467.453

10482.919

Debt/Equity ratio

(26.319)

(4.371)

(1.720)

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

4171.665

3077.483

2672.027

 

 

(26.229)

(13.175)

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

4171.665

3077.483

2672.027

Profit

(1451.276)

(1999.400)

(3638.082)

 

(34.79)%

(64.97)%

(136.15)%

 

 

ABRIDGED BALANCE SHEET (CONSOLIDATED)

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

250.329

242.694

(b) Reserves & Surplus

 

(6448.900)

(2763.847)

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

66.810

Total Shareholders’ Funds (1) + (2)

 

(6198.571)

(2454.343)

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

6647.699

6716.524

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

48.086

56.386

(d) long-term provisions

 

26.375

20.403

Total Non-current Liabilities (3)

 

6722.160

6793.313

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

3835.220

3712.534

(b) Trade payables

 

1617.599

1753.814

(c) Other current liabilities

 

621.071

742.963

(d) Short-term provisions

 

0.000

0.000

Total Current Liabilities (4)

 

6073.890

6209.311

 

 

 

 

TOTAL

 

6597.479

10548.281

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

3146.886

3442.934

(ii) Intangible Assets

 

276.237

298.507

(iii) Capital work-in-progress

 

22.175

22.175

(iv) Intangible assets under development

 

0.000

14.499

(b) Non-current Investments

 

345.951

391.692

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

127.871

163.122

(e) Other Non-current assets

 

0.000

98.900

Total Non-Current Assets

 

3919.120

4431.829

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

390.598

909.405

(c) Trade receivables

 

1084.810

3803.303

(d) Cash and cash equivalents

 

91.051

173.896

(e) Short-term loans and advances

 

820.622

869.109

(f) Other current assets

 

291.278

360.739

Total Current Assets

 

2678.359

6116.452

 

 

 

 

TOTAL

 

6597.479

10548.281

 

 

PROFIT & LOSS ACCOUNT (CONSOLIDATED)

 

 

PARTICULARS

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Income

 

2672.027

3077.483

 

Other Income

 

109.293

125.050

 

TOTAL

 

2781.320

3202.533

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

1672.082

2190.411

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(39.302)

14.369

 

Employees benefits expense

 

423.300

403.698

 

Other expenses

 

3833.906

2038.515

 

TOTAL

 

5889.986

4646.993

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

(3108.666)

(1444.460)

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

163.159

189.679

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION

 

(3271.825)

(1634.139)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

357.322

363.515

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

 

(3629.147)

(1997.654)

 

 

 

 

 

Less

TAX

 

8.935

1.746

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

 

(3638.082)

(1999.400)

 

 

 

 

 

 

Share of Profit/ (Loss) from an Associates

 

(84.406)

(136.504)

 

 

 

 

 

 

Net Profit / Loss for the year

 

(3722.488)

(2135.904)

 

 

 

 

 

 

Earnings / (Loss) Per Share (INR)

 

 (68.73)

(42.42) 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of establishment

Yes

2]

Constitution of the entity Incorporation details

Yes

3]

Locality of the entity

Yes

4]

Premises details

No

5]

Buyer visit details

--

6]

Contact numbers

Yes

7]

Name of the person contacted

No

8]

Designation of contact person

No

9]

Promoter’s background

Yes

10]

Date of Birth of Proprietor / Partners / Directors

Yes

11]

Pan Card No. of Proprietor / Partners

No

12]

Voter Id Card No. of Proprietor / Partners

No

13]

Type of business

Yes

14]

Line of Business

Yes

15]

Export/import details (if applicable)

No

16]

No. of employees

Yes

17]

Details of sister concerns

Yes

18]

Major suppliers

No

19]

Major customers

No

20]

Banking Details

Yes

21]

Banking facility details

Yes

22]

Conduct of the banking account

--

23]

Financials, if provided

Yes

24]

Capital in the business

Yes

25]

Last accounts filed at ROC, if applicable

Yes

26]

Turnover of firm for last three years

Yes

27]

Reasons for variation <> 20%

--

28]

Estimation for coming financial year

No

29]

Profitability for last three years

Yes

30]

Major shareholders, if available

Yes

31]

External Agency Rating, if available

No

32]

Litigations that the firm/promoter involved in

--

33]

Market information

--

34]

Payments terms

No

35]

Negative Reporting by Auditors in the Annual Report

No

 

MANAGEMENT DISCUSSION AND ANALYSIS REPORT

 

INDUSTRY STRUCTURE AND DEVELOPMENT:

The pharmaceutical industry is one of the fastest growing industries in the world and it is one of the biggest contributors to the world economy. The major sales of the pharmaceutical products come from the “Triad” (US, EU and Japan) in the world. The size of world pharmaceutical market in 2014 was around USD 1.2 Trillion and is estimated to be USD 1.4 trillion by 2020. According to IMS health report, it is projected that, US contributes about 41 percent of total sales of medicine in the word by 2020, followed by EU5 and Chain which are projected to spend about 13 percent and 11 percent respectively. Brazil, Russia and India put together contribute about 6 percent of global consumption of the medicine. According to Equity Master Report, Indian pharmaceutical industry is the third largest, in terms of volume and it is number thirteen in terms of value in the world market. The Indian pharmaceutical sector accounts for 10 percent in volume terms and 2.4 percent of in value terms, the world market. The Present market size of the Indian pharmaceutical sector is USD 20 billion and expected to reach USD 55 billion by the year 2020 with a compound annual growth rate (CAGR) of 15.92 per cent between 2015 and 2020. It is projected to grow more than the annual growth rate of the world pharmaceutical sector, which is estimated about 5 per cent between same periods.

 

OPERATIONS REVIEW & COMPANY'S OUTLOOK

Exports through the state of the art manufacturing facilities at Derabassi Punjab continued to be the main stay of the Company. Besides the Exports, Company is also focusing to increase its presence in the Domestic Markets. The Gynaecology and pediatric segments of the Company are performing streadily. During the year we have taken initiative in domestic sale by increasing the field force by 15% & also adding two new molecules in Gynae AND Derma therapy area which definitely will yield results during the year in progress. And in our healthcare segment, we have added 15 new products. We have also started a new Division with the name NOVA for Diabetic/Cardio & Hapatology therapy areas, which is definitely going to give dividend in the next coming few years. Since all these therapeutic segments are fastest growing & will remain so.

 

UNSECURED LOAN

 

PARTICULAR

31.03.2017

(INR in Million)

31.03.2016

(INR in Million)

Long-term Borrowings

 

 

Fixed Deposit from Public

201.962

246.125

 

 

 

Short-term borrowings

 

 

From Banks

17.198

32.380

From Financial Institution

125.819

105.155

Fixed Deposit from Public

96.712

75.052

Total

441.691

458.712

 

INDEX OF CHARGES

SNo

SRN

Charge Id

Charge Holder Name

Date of Creation

Date of Modification

Date of Satisfaction

Amount

Address

1

G49121247

10421176

PUNJAB NATIONAL BANK

28/03/2013

30/09/2016

-

10028700000.0

SECTOR 28 CHANDIGARH-160028 INDIA

2

B79477675

10403081

State Bank of India

29/01/2013

06/07/2013

-

9768600000.0

SCBSECTOR 17-B CHANDIGARH-160017 INDIA

3

G33078148

10410964

EDELWEISS ASSET RECONSTRUCTION COMPANY LIMITED

19/01/2013

31/03/2016

-

1507700000.0

EDELWEISS HOUSE, OFF. C.S.T ROAD, KALINA,MUMBAI-400098 MAHARASHTRA INDIA

4

G04801973

10361298

EDELWEISS ASSET RECONSTRUCTION COMPANY LIMITED

01/06/2012

23/03/2016

-

300000000.0

EDELWEISS HOUSE, OFF. C.S.T ROAD, KALINA,MUMBAI-400098 MAHARASHTRA, INDIA

5

G72907868

10354686

EDELWEISS ASSET RECONSTRUCTION COMPANY LIMITED

10/05/2012

31/03/2017

-

150000000.0

EDELWEISS HOUSE, OFF. C.S.T ROAD, KALINA,MUMBAI-400098 MAHARASHTRA, INDIA

6

B37178340

10348283

Bank of India

14/03/2012

-

-

500000000.0

NIHON SELMEL SAKAISUJI HONMACHI BLDG 8-12,HONMACHI 1-CHOME, CHUO-KU, PO BOX 14,OSAKANA5410053JP

7

B32804270

10337188

IDBI Bank Limited

10/02/2012

-

-

200000000.0

IDBI TOWERWTC COMPLEXCUFFE PARADEMUMBAIMH400005IN

8

G33080649

10326217

EDELWEISS ASSET RECONSTRUCTION COMPANY LIMITED

22/12/2011

31/03/2016

-

350000000.0

EDELWEISS HOUSE, OFF. C.S.T ROAD, KALINA,MUMBAI-400098 MAHARASHTRA, INDIA

9

B26348292

10320222

EXPORT-IMPORT BANK OF INDIA

24/11/2011

-

-

300000000.0

CENTER ONE BUILDING,FLOOR-21WORLD TRADE CENTER COMPLEX, CUFFE PARADE MUMBAI-400005 MAHARASHTRA, INDIA

10

B25453986

10318051

DIRECTOR OF INDUSTIRES

17/11/2011

-

-

3000000.0

DY.DIRECTOR OF INDUSTRIESS.W.C.A BADDI ,DISTT SOLAN BADDI-173205 INDIA

 

CONTINGENT LIABILITIES:

 

a) Foreign Letter of Credit/Inland Letter of Credit/Bank Guarantee issued by Bankers:

(INR in million)

PARTICULARS

31.03.2015

BG

1.601

 

b) Arrears of Cumulative Dividend on cumulative Redeemable Preference Shares amounting to INR 8.520 Million Previous year (INR 7.100 Million).

 

c) In respect of Income Tax matters pending before appellate authorities/Tribunal/High Courts which the Company expects to succeed, based on decisions of Tribunals/Courts there is contingent liability amounting to INR 44.793 Million.

d) In respect of Sale Tax matters pending before appellate authorities/Tribunal/High Courts which the Company expects to succeed, based on decisions of Tribunals/Courts there is contingent liability amounting to INR 84.625 Million.

 

e) In respect of Service Tax matters pending before appellate authorities/Tribunal which the Company expects to succeed, based on decisions of Tribunals/Courts. There is contingent liability amounting to INR 18.382 Million.

 

f) In respect of Central Excise matters pending before appellate authorities/Tribunal which the Company expects to succeed, based on decisions of Tribunals/Courts. There is contingent liability amounting to INR 140.163 Million.

 

 

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED / NINE MONTHS ON DECEMBER 2017

 

[INR IN MILLION]

PARTICULARS

 

 

 

Quarter Ended

9 Months Ended

31.12.2017

[Unaudited]

30.09.2017

[Unaudited]

31.12.2017

[Unaudited]

 Income from Operations

 

 

 

Revenue from operations

767.974

713.138

2007.193

Other Operating Income

2.059

2.080

14.556

Total income from operations (net)

770.033

715.218

2021.749                                                                                                                                                 

Expenses

 

 

 

Cost of materials consumed

312.664

294.335

879.919

Purchase of stock in trade

116.972

82.710

285.657

Changes in inventories of finished goods. work-in-progress and stock in trade

12.121

51.423

12.151

Employee benefits expense

115.049

110.963

336.807

Finance Cost

24.089

17.416

71.863

Depreciation and Amortization Expenses

86.228

86.133

258.320

Other Expenses

242.857

214.691

605.033

Total expenses

909.980

857.671

2449.750

Profit/ (Loss) before exceptional items

(139.947)

(142.453)

(428.001)

Exceptional items

-

-

-

Profit/ (Loss) before tax

(139.947)

(142.453)

(428.001)

Tax expenses

0.000

0.000

0.000

Net Profit / (Loss) for the period (11-12)

(139.947)

(142.453)

(428.001)

Paid up equity share capital (Face Value of INR 2each)

108.329

108.329

108.329

Earning per share INR 2/- Each

 

 

 

(a) Basic

(2.58)

(2.63)

(7.90)

(b) Diluted

(2.58)

(2.63)

(7.90)

 

Note:

1. During this quarter some banks/ Assets Reconstruction Companies (ARC'S) have not charged interest due to NPA status of account on cash credit, Term Loans, Working Capital Term Loans and Funded Interest Term Loans accounts. Also some banks/ARC's have not provided bank statements due to which interest charged figures are not available. Hence the accrued liability on account of the same amounting to INR 372.530 million, has not been provided in books of accounts.


2. Other expenses for this quarter include Provision for Doubtful Debts/Debts Written off for INR 125.000 million which has been made in accounts on proportionate basis in respect of debts considered to be doubtful of  recovery.

3. The Company has First time adopted IND-AS with effect from 1 st April 2017, with the transition date of 1 st April 2016, The unaudited financial results have been prepared by the company in accordance with the Companies (Indian Accounting Standard) Rules 2015 (IND-AS) prescribed under section 133 of the companies act 2013 and other recognised accounting practices and policies to the extent applicable.


4. The statement does not include Ind-AS compliant results for the previous year ended 31 st March 2017 as the same is not mandatory as per SEBI circular dated 5th July 2016.

 

 

FIXED ASSETS

·         Land Leasehold Land

·         Building

·         Plant and Equipment

·         Furniture and Fixture

·         Vehicles

·         Office Equipment

·         Misc Fixed Assets

·         Building (R&D)

·         Furniture & Fixture (R&D)

·         Equipment (R&D)

·         Land (R&D)

·         Patent & Trade Mark

·         Product Technology

·         Software

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

 INR 64.82

UK Pound

1

INR 79.94

Euro

1

INR 90.66

 

 

INFORMATION DETAILS

 

Information Gathered by :

KAM

 

 

Analysis Done by :

PRI

 

 

Report Prepared by :

RKI

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.